• Latest Posts

 Six Toronto-based biotech companies to watch this year

Depression trial gets green light

Potential new lead compounds for treatment of depression and anxiety disorders

Beckley Psytech completes treatment resistant depression and alcohol use disorder study


Beckley Psytech acquires Eleusis Therapeutics

Axsome Therapeutics’ MDD treatment gets green light from FDA

Approval for Small Pharma major depressive disorder clinical trial

Relmada Therapeutics gets Fast Track designation for major depressive disorder treatment

Positive news from trial for drug to treat major depressive disorder